Geron Corporation (GERN) - Latest Market Data

Price & Market Data

Price: $1.37

Daily Change: -$0.02 / 1.46%

Range: $1.37 - $1.37

Market Cap: $885,309,120

Volume: 330

Performance Metrics

1 Week: 11.20%

1 Month: -20.57%

3 Months: -53.51%

6 Months: -66.01%

1 Year: -62.33%

YTD: -60.73%

Company Details

Employees: 229

Sector: Health technology

Industry: Biotechnology

Country: United States

Details

Geron Corporation, a commercial-stage biopharmaceutical company, focuses on the development of therapeutics products for oncology. It offers RYTELO a telomerase inhibitor for the treatment f adult patients with low- to intermediate-1 risk myelodysplastic syndromes with transfusion-dependent anemia. The company was incorporated in 1990 and is headquartered in Foster City, California.

Selected stocks

Under Armour, Inc. (UAA)

Darling Ingredients Inc. (DAR)

D.R. Horton, Inc. (DHI)